Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022

MMWR Morbidity and Mortality Weekly Report(2022)10.15585/mmwr.mm7145a2Source: DataRank Database

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022 is a research paper published in MMWR Morbidity and Mortality Weekly Report (2022). On theSindex it has a DataRank of 0.765. It has been cited 163 times.

N/A

0.765DataRank · unranked

Scored on demand from live citation data

Open Access163 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 14.49)OA: goldTopics (29)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.765

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (18)

Megan J. Wallace ORCID,Monica Godfrey,Lauren E. Roper,Elisha Hall ORCID,Katherine E. Fleming-Dutra ORCID

Live enrichment

PubMed:36355612 PMC:PMC9707353 OpenAlex:https://openalex.org/W4308668146

FWCI

14.49

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: public-domain

journalhttps://www.cdc.gov/mmwr/volumes/71/wr/pdfs/mm7145a2-H.pdf

publisherhttps://www.cdc.gov/mmwr/volumes/71/wr/pdfs/mm7145a2-H.pdf

journalhttps://doi.org/10.15585/mmwr.mm7145a2

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36355612

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9707353

Fields of Study

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyVirus-based gene therapy research

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesBNT162 VaccineHumansImmunizationImmunization, SecondaryRNA, MessengerUnited StatesVaccinationAdvisory Committees

Keywords

Bivalent (engine)MedicineBooster doseBooster (rocketry)InterimVaccinationCoronavirus disease 2019 (COVID-19)VirologyAdvisory committeeFamily medicineTiterVirusInternal medicineLawManagement

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Estimated public health impact of concurrent mask mandate and vaccinate-or-test requirement in Illinois, October to December 2021

10.6084/m9.figshare.25596387.v1figshare

Additional file 1 of Estimated public health impact of concurrent mask mandate and vaccinate-or-test requirement in Illinois, October to December 2021

10.6084/m9.figshare.25596387figshare

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022

FAIR Checklist

DataRank Breakdown

Authors (18)

Impact

Open Access

Topics

Linked Datasets (2)

Annotations (Europe PMC)